<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        162-9-19
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PATADAY 0.2% OPHTHALMIC SOLUTION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        OLOPATADINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Ocular use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Eye drops, solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Dropper Container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        37.9
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="ALCON LABORATORIES" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            ALCON LABORATORIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 439]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Novartis Saudi Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            NOVARTIS PHARMA AG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S01GX09
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>PATADAY&reg; containing the active substance Olopatadine Hydrochloride.<br />PATADAY is used for the treatment of itchy eyes caused by seasonal allergies.<br /><strong>How does PATADAY work?</strong><br />Itchy eyes due to seasonal allergies, also called allergic conjunctivitis, happens when allergens<br />like pollen cause the cells of the eye to release a chemical called histamine. This can result in<br />Read all of this leaflet carefully before you start using this medicine.<br />- Keep this leaflet. You may need to read it again.<br />- If you have any further questions, ask your doctor, health care provider or pharmacist.<br />- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if<br />their symptoms are the same as yours.<br />- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet,<br />please tell your doctor, health care provider or pharmacist.<br />itching, redness and swelling on the surface of your eye. PATADAY works by stopping the release of histamine and other chemicals that cause the allergic reaction. This reduces eye itching.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use PATADAY if:</strong><br />&bull; you are allergic to olopatadine hydrochloride or to any of the other ingredients (see What<br />PATADAY contains?).<br /><strong>To help avoid side effects and ensure proper use, talk to your healthcare professional before<br />you take PATADAY. Talk about any health conditions or problems you may have, including<br />if you:</strong><br />&bull; are pregnant or planning to become pregnant.<br />&bull; are breastfeeding. PATADAY may pass into breastmilk.<br />&bull; are under 18 years of age.<br /><strong>Other warnings you should know about:<br />&bull; Use of PATADAY and use of contact lenses:</strong><br />&bull; Do not wear contact lenses if your eyes are red.<br />&bull; PATADAY contains a preservative, benzalkonium chloride, which may cause eye<br />irritation and is known to discolour soft contact lenses. Do not use PATADAY while<br />wearing contact lenses.<br />&bull; Remove your contacts before using PATADAY and wait at least 15 minutes before<br />putting your contacts back in.<br /><strong>&bull; Use of PATADAY with other eye drops or ointments:</strong><br />&bull; If you use other eye drops, wait at least 5 minutes between putting in PATADAY and the<br />other drops.<br />&bull; Apply eye ointments last.<br /><strong>&bull; Driving and using machines:</strong> You may find that your vision is blurred for a time just after<br />you use PATADAY. Do not drive or use machines until your vision is clear.<br /><strong>Tell your healthcare professional about all the medicines you take, including any drugs,<br />vitamins, minerals, natural supplements or alternative medicines.</strong><br /><strong>The following may interact with PATADAY:</strong><br />There are no known drugs that interact with PATADAY.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; PATADAY is an eye drop. Only use it in your eye(s).<br />&bull; Use PATADAY exactly how your healthcare professional has told you to. Do not change<br />your dose without talking to your healthcare professional.<br /><strong>Usual dose:</strong><br />Adults: 1 drop in each affected eye once daily.</p><p><img src="data:image/jpeg;base64,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" alt="" width="496" height="306" vspace="0" hspace="0" border="0" style="width:496px;height:306px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /><img src="data:image/jpeg;base64,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" alt="" width="495" height="299" vspace="0" hspace="0" border="0" style="width:495px;height:299px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /><br />&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<strong> &nbsp;1&nbsp; </strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;2</strong><br /><strong>Instructions for use:</strong><br />1. Get the PATADAY bottle and a mirror if needed.<br />2. Wash your hands.<br />3. Twist off the cap, being careful not to touch the dropper tip.<br />4. Hold the bottle, pointing it down, between your thumb and<br />middle finger.<br />5. Tilt your head back. Pull down your eyelid with a clean finger, until there is a &lsquo;pocket&rsquo;<br />between the eyelid and your eye. The drop will go in there (Figure 1).<br />6. Bring the bottle tip close to the eye. Use the mirror if it helps.<br /><strong>Do not touch your eye or eyelid, or any surface with the dropper. </strong>It could contaminate<br />the drops, cause an eye infection and damage the eyes.<br />7. Gently press the bottom of the bottle with your forefinger to<br />release one drop (Figure 2). Do not squeeze the bottle: it is designed so that just a gentle<br />press on the bottom is all that it needs.<br />8. If you use drops in both eyes, repeat the steps for the other eye.<br />9. Put the bottle cap firmly back on immediately after use.<br /><strong>Overdose:</strong><br />If you get too much in your eyes, rinse it all out with warm water. Don&rsquo;t put in any more drops<br />until it&rsquo;s time for your next regular dose.<br />If you think you, or a person you are caring for, have taken too much PATADAY, contact a<br />healthcare professional, hospital emergency department, or regional poison control center<br />immediately, even if there are no symptoms.<br /><strong>Missed Dose:</strong><br />If you forget to use PATADAY, use a single drop as soon as you remember, and then go back to<br />your regular routine. <strong>Do not use</strong> a double dose to make up for the one missed.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>These are not all the possible side affects you may have when taking PATADAY. If you<br />experience any side effects not listed here, tell your healthcare professional.<br />Side effects may include:<br />In the eye:<br />&bull; eye problems such as dry, itchy, red, irritated or crusted eyes<br />&bull; eye surface inflammation with or without surface damage<br />&bull; eye discharge<br />&bull; eye pain<br />&bull; increased tear production<br />&bull; eyelid redness, swelling<br />&bull; sensitivity to light<br />&bull; blurred vision<br />&bull; burning, stinging or gritty feeling or a feeling as if something is trapped in the eye<br />Other areas of your body:<br />&bull; headache<br />&bull; dizziness<br />&bull; fatigue or tiredness<br />&bull; nasal dryness<br />&bull; a dry mouth<br />&bull; a change in your sense of taste<br />&bull; nausea<br />&bull; red or itchy skin</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:624px"><tbody><tr><td colspan="5" style="vertical-align:top">&nbsp;<p><strong>Serious side effects and what to do about them</strong></p></td><td><p>&nbsp;</p></td></tr></tbody><thead><tr><td><p>&nbsp;</p></td><td rowspan="2"><p><strong>Symptom / effect</strong></p></td><td colspan="2"><p><strong>Talk to your&nbsp; healthcare professional</strong></p></td><td colspan="2" rowspan="2"><p><strong>Stop taking drug and get immediate medical help</strong></p></td></tr><tr><td><p>&nbsp;</p></td><td><p><strong>Only if severe</strong></p></td><td><p><strong>In all cases</strong></p></td></tr></thead><tbody><tr><td><p>&nbsp;</p></td><td><p><strong>RARE</strong></p></td><td><p><strong><u>&nbsp;</u></strong></p></td><td><p><u>&nbsp;</u></p></td><td colspan="2"><p><u>&nbsp;</u></p></td></tr><tr><td><p>&nbsp;</p></td><td><p><strong>Allergic reactions:</strong>&nbsp; swelling of the face, lips, tongue, mouth or throat, shortness of breath, difficulty swallowing, hives, severe itching and rash, nausea, vomiting</p></td><td><p><strong><u>&nbsp;</u></strong></p></td><td><p><u>&nbsp;</u></p></td><td colspan="2"><p><strong>✓</strong></p></td></tr><tr><td><p>&nbsp;</p></td><td><p><strong>Increased heart rate</strong></p></td><td><p><strong><u>&nbsp;</u></strong></p></td><td><p><strong>✓</strong></p></td><td colspan="2"><p><strong>&nbsp;</strong></p></td></tr></tbody></table><p>If you have a troublesome symptom or side effect that is not listed here or becomes bad enough<br />to interfere with your daily activities, tell your healthcare professional.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Store below 30&ordm;C<br />&bull; Throw away the bottle at the end of your treatment or 4 weeks after first opening whichever<br />comes first.<br />&bull; Keep out of reach and sight of children.<br />&bull; Medicines should not be disposed of via wastewater or household waste. Ask your<br />pharmacist how to dispose of medicines no longer required. These measures will help to<br />protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Medicinal ingredients: olopatadine hydrochloride<br />Non-medicinal ingredients: benzalkonium chloride (preservative), disodium phosphate, edetate<br />disodium, hydrochloric acid and/or sodium hydroxide (to adjust pH), povidone, purified water,<br />sodium chloride.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Ophthalmic solution (eye drops); 0.2% w/v
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The Marketing Authorization Holder for this Product is Novartis Pharma AG.<br />www.Novartis.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised by Canada in (June/2023)

• Saudi Arabia
The National Pharmacovigilance Centre (NPC):
o SFDA call center: 19999
o E-mail: npc.drug@sfda.gov.sa
o Website: https://ade.sfda.gov.sa
Patient Safety Department Novartis Consulting AG - Saudi Arabia:
o Toll Free Number: 8001240078
o Phone: +966112658100
o Fax: +966112658107
o Email: adverse.events@novartis.com
• Other GCC States:
- Please contact the relevant competent authority.
f. To report any complaint(s): complaints.ksa@novartis.com
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">باتاداي&nbsp;يحتوي على المادة الفعالة أولوباتادين هيدروكلوريد. &reg; باتاداي<br />يُستخدم باتاداي لعلاج حكَّة العينين الناجمة عن حالات الحساسية الموسمية.<br /><strong>كيف يعمل باتاداي؟</strong><br />تحدث حكة العينين بسبب حالات الحساسية الموسمية، والتي تُسمى أيضًا التهاب الملتحمة التحسّسي، عندما تتسبب مسببات<br />الحساسية مثل حبوب اللقاح في إطلاق خلايا العين لمواد كيميائية تُسمى الهيستامين. يمكن أن يؤدي ذلك إلى حكة، واحمرار<br />يُرجى قراءة هذه النَّشرة كاملة بعناية قبل أن تبدأ في استخدام هذا الدواء؛ لأنها تحتوي على معلومات هامّة بالنِّّسبة لك.<br />- احتفظ بهذه النشرة؛ فقد تحتاج إلى قراءتها مرة أخرى .<br />- إذا كانت لديك أية أسئلة أخرى، فاستشر طبيبك، أو الصيدلي، أو الممرض .<br />- تم وصف هذا الدَّواء لك وحدك، فلا تعطه لآخرين؛ فقد يضر بهم، حتى إذا كانوا يُعانون من نفس علامات المرض التي تعاني<br />منها .<br />- إذا أُصبت بأية آثار جانبية، فتحدَّث إلى طبيبك أو الصيدلي أو الممرض. ويشمل ذلك أية آثار جانبية مُحتمَلة، غير المُدرجة في<br />هذه النَّشرة.<br />وتورّم على سطح العين. يعمل باتاداي عن طريق إيقاف إطلاق الهيستامين والمواد الكيميائية الأخرى التي تسبب رد الفعل<br />التحسّسي. وهذا يقلل من حكة العين.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>أ. موانع استعمال باتاداي:<br />&bull;<br />إذا كانت لديك حساسية تجاه أولوباتادين هيدروكلوريد أو لأي من المكونات الأخرى )انظر ما محتويات باتاداي؟(.<br />للمساعدة على تجنب الآثار الجانبية وضمان الاستخدام السليم، تحدّث إلى اختصاصي الرعاية الصحية قبل تناول باتاداي.<br />وتحدث عن أي حالات صحية أو مشكلات قد تعاني منها، بما في ذلك إذا:<br />&bull;<br />كنتِ حاملًا أو تخططين للحمل.<br />&bull;<br />كنتِ ترضعين رضاعة طبيعية. فقد ينتقل باتاداي إلى حليب الثدي.<br />&bull;<br />كنت دون سن 18 عامًا .<br />الاحتياطات عند استعمال باتاداي:<br />&bull;<br />استخدام باتاداي واستخدام العدسات اللاصقة:<br />&bull;<br />لا ترتدِ العدسات اللاصقة إذا كانت عينيك حمراء.<br />&bull;<br />يحتوي باتاداي على مادة حافظة، كلوريد البنزالكونيوم، والتي قد تسبب تهيّج العين ومن المعروف أنها تغيِّر لون<br />العدسات اللاصقة الليّنة. فلا تستخدم باتاداي أثناء ارتداء العدسات اللاصقة .<br />&bull;<br />قم بإزالة العدسات اللاصقة الخاصة بك قبل استخدام باتاداي وانتظر 15 دقيقة على الأقل قبل إعادة وضعها.<br />&bull;<br />استخدام باتاداي مع قطرات أو مراهم أخرى للعين:<br />&bull;<br />إذا كنت تستخدم قطرات أخرى للعين، فانتظر 5 دقائق على الأقل بين وضع باتاداي والقطرات الأخرى .<br />&bull;<br />ضع مراهم العين أخيرًا .<br />&bull;<br />قيادة السيارة واستعمال الآلات:قد تجد أن رؤيتك غير واضحة لبعض الوقت بعد استخدام باتاداي مباشرةً. لا تقد السيارة<br />أو تستخدم الآلات حتى تصبح رؤيتك واضحة.<br />أخبر اختصاصي الرعاية الصحية المتابع لك بجميع الأدوية التي تتناولها، بما في ذلك أي عقاقير، أو فيتامينات، أو معادن،<br />أو مكملات طبيعية أو أدوية بديلة .<br />قد يتفاعل ما يلي مع باتاداي:<br />لا توجد عقاقير معروفة تتفاعل مع باتاداي.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">باتاداي عبارة عن قطرة للعين. استخدمها فقط في عينك )عينيك(.<br />استخدم باتاداي تمامًا كما قد أخبرك اختصاصي الرعاية الصحية المتابع لك. ولا تغيّر جرعتك دون التحدّث إلى اختصاصي الرعاية الصحية المتابع لك.</p><p dir="RTL"><strong>الجرعة المعتادة:</strong><br />للبالغين: قطرة واحدة في كل عين مصابة مرة واحدة يوميًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><img src="data:image/jpeg;base64,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" alt="" width="496" height="306" vspace="0" hspace="0" border="0" style="width:496px;height:306px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /><img src="data:image/jpeg;base64,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" alt="" width="495" height="299" vspace="0" hspace="0" border="0" style="width:495px;height:299px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تعليمات الاستخدام:</strong><br />1 . احصل على زجاجة باتاداي ومرآة إذا لزم الأمر .<br />2 . اغسل يديك .<br />3 . لف الغطاء، مع الحرص على عدم لمس طرف القطّارة.<br />4 . أمسك الزجاجة، مع توجيهها لأسفل، بين إبهامك والإصبع الأوسط.<br />5 . قم بإمالة رأسك للخلف. واسحب جفنك لأسفل بإصبع نظيف، حتى يكون هناك &quot;جيب&quot; بين الجفن وعينك. ستذهب القطرة<br />إلى هناك )الشكل 1 . )<br />6 . ضع طرف الزجاجة بالقرب من العين. واستخدم المرآة إذا كان ذلك مفيدًا.<br />لا تلمس عينك أو جِّفنك، أو أي سطح بالقطارة . فقد يؤدي ذلك إلى تلوث القطرات، وتسبب عدوى في العين وتلف العينين.<br />7 . اضغط برفق على الجزء السفلي من الزجاجة باستخدام إصبع السبابة لإطلاق قطرة واحدة )الشكل 2 (. لا تعصر<br />الزجاجة: فهي مصممة بحيث تكون مجرد ضغطة خفيفة في الأسفل كل ما تحتاجه.<br />8 . إذا كنت تستخدم قطرات في كلتا العينين، فكرر الخطوات الخاصة بالعين الأخرى.<br />9 . أعد وضع غطاء الزجاجة بإحكام بعد الاستخدام مباشرة.<br /><strong>الجرعة الزائدة:</strong><br />إذا كنت تعاني من وجود الكثير في عينيك، فاشطفهما بالماء الدافئ. لا تضع المزيد من القطرات حتى يحين وقت جرعتك<br />المعتادة التالية.<br />إذا كنت تعتقد أنك، أو شخص تعتني به، قد استخدمت الكثير من باتاداي، فاتصل باختصاصي رعاية صحية، أو قسم<br />طوارئ في المستشفى، أو مركز إقليمي لمكافحة السموم على الفور، حتى لو لم تكن هناك أعراض.<br /><strong>الجرعة الفائتة:</strong><br />إذا نسيت استخدام باتاداي، فاستخدم قطرة واحدة بمجرد أن تتذكر، ثم ارجع إلى روتينك المعتاد. لا تستخدم جرعة مضاعفة<br />لتعويض الجرعة الفائتة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">هذه ليست جميع الآثار الجانبية المحتملة التي قد تعاني منها عند أخذ باتاداي. إذا عانيت من أي آثار جانبية غير مُدرجة هنا،<br />فأخبر اختصاصي الرعاية الصحية المتابع لك.</p><p dir="RTL">قد تشمل الآثار الجانبية:<br />في العين :<br />&bull;مشكلات في العين مثل جفاف العينين، أو الحكة، أو الاحمرار، أو تهيّج أو تقشرهما<br />&bull;التهاب سطح العين مع أو دون تلف السط ح<br />&bull;إفرازات العين<br />&bull;ألم في العين<br />&bull;زيادة إنتاج الدموع<br />&bull;احمرار الجفن، تورم<br />&bull;الحساسية للضوء<br />&bull;ضبابية الرؤية<br />&bull;الشعور بحرقان، أو لسع أو رمل أو شعور وكأن شيئًا ما محاصرًا في العين<br />مناطق أخرى من جسمك:<br />&bull;الصداع<br />&bull;الدوخة<br />&bull;التعب أو الإرهاق<br />&bull;جفاف الأنف<br />&bull;جفاف الفم<br />&bull;تغيّر في حاسة التذوق لدي ك<br />&bull;الغثيان<br />&bull;احمرار الجلد أو حكة فيه</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:624px"><tbody><tr><td colspan="5" style="vertical-align:top">&nbsp;<p dir="RTL"><strong>الآثار الجانبية الخطيرة وما يجب فعله حيالها</strong></p></td><td><p>&nbsp;</p></td></tr></tbody><thead><tr><td><p>&nbsp;</p></td><td rowspan="2"><p dir="RTL"><strong>العَرَض/الأثر</strong></p></td><td colspan="2"><p dir="RTL"><strong>تحدّث إلى اختصاصي الرعاية الصحية المتابع&nbsp;لك</strong></p></td><td colspan="2" rowspan="2"><p dir="RTL"><strong>توقف عن أخذ العقار واحصل على مساعدة طبية فورية</strong></p></td></tr><tr><td><p>&nbsp;</p></td><td><p dir="RTL"><strong>فقط إذا كان شديدًا</strong></p></td><td><p dir="RTL"><strong>في جميع الحالات</strong></p></td></tr></thead><tbody><tr><td><p>&nbsp;</p></td><td><p dir="RTL"><strong>نادر</strong></p></td><td><p dir="RTL"><u>&nbsp;</u></p></td><td><p dir="RTL"><u>&nbsp;</u></p></td><td colspan="2"><p dir="RTL"><u>&nbsp;</u></p></td></tr><tr><td><p>&nbsp;</p></td><td><p dir="RTL"><strong>ردود الفعل التحسّسية: </strong>تورُّم الوجه، أو الشفتين، أو اللسان، أو الفم أو الحُلق، ضيق التنفس، صعوبة البلع، الشرى، الحكة الشديدة والطفح الجلدي، الغثيان،&nbsp;التقيؤ</p></td><td><p dir="RTL"><u>&nbsp;</u></p></td><td><p dir="RTL"><u>&nbsp;</u></p></td><td colspan="2"><p dir="RTL">✓</p></td></tr><tr><td><p>&nbsp;</p></td><td><p dir="RTL"><strong>زيادة معدل ضربات القلب</strong></p></td><td><p dir="RTL"><u>&nbsp;</u></p></td><td><p dir="RTL">✓</p></td><td colspan="2"><p dir="RTL">&nbsp;</p></td></tr></tbody></table><p dir="RTL">إذا كنت تعاني من عَرض أو أثر جانبي مزعج غير مُدرج هنا أو أصبح سيئًا بما يكفي للتدّخل في أنشطتك اليومية، فأخبر<br />اختصاصي الرعاية الصحية المتابع لك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&bull; يُحفَظ في درجة حرارة أقل من 30 درجة مئوية<br />&bull; تخلّص من الزجاجة في نهاية علاجك أو بعد 4 أسابيع من فتحها لأول مرة أيهما يأتي أولاً.<br />&bull; يُحفَظ بعيدًا عن متناول ومرأى الأطفال.<br />&bull; ينبغي عدم التخلص من الأدوية في مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلّص من<br />الأدوية التي لم تعد هناك حاجة إليها. ستساعد هذه التدابير على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المكونات الدوائية: أولوباتادين هيدروكلوريد<br />المكونات غير الدوائية: كلوريد البنزالكونيوم )مادة حافظة(، فوسفات ثنائي الصوديوم، اديتات ثنائي الصوديوم، حمض<br />الهيدروكلوريك و/أو هيدروكسيد الصوديوم )لتعديل درجة الحموضة(، بوفيدون، ماء منقى، كلوريد الصوديوم .</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">محلول العين )قطرات العين(؛ 0.2 % وزن/حج م</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مالك حق التسويق لهذا المنتج هي شركة نوفارتس فارما إيه ج ي .<br />www.Novartis.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم اعتماد هذه النَّشرة من قبل كندا في يونيو/ 2023

ه. للإبلاغ عن الأعراض الجانبية:
•المملكة العربية السعودية
- المركز الوطني للتيقظ والسلامة الدوائية ) NPC )
•مركز اتصال الهيئة السعودية للغذاء والدواء: 19999
•البريد الالكتروني: npc.drug@sfda.gov.sa
•الموقع الالكتروني: https://ade.sfda.gov.sa
- شركة نوفارتس - السعودية - قسم سلامة المرضى :
•الهاتف المجاني: 8001240078
•الهاتف: +966112658100
•الفاكس: +966112658107
•البريد الالكتروني: adverse.events@novartis.com
•دول مجلس التَّعاون الخليجي الأخرى:
- يُرجى الاتصال بسلطات الاختصاص المعنية

و. للإبلاغ عن أي شكوى: complaints.ksa@novartis.com
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                PATADAY® (olopatadine hydrochloride ophthalmic solution).
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each mL of PATADAY contains:
Medicinal ingredient: 2.22 mg olopatadine hydrochloride equivalent to 2 mg olopatadine.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                PATADAY is supplied in a white, oval, low density polyethylene bottle with a natural low density polyethylene dispensing plug and a white polypropylene cap.
Net contents are 2.5 mL in a 4 mL bottle.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>PATADAY&reg; solution is indicated for:<br />&bull; the treatment of ocular itching associated with seasonal allergic conjunctivitis.</p><p><br /><strong>Special population</strong><br /><strong>&bull; Pediatric population:</strong><br />The effectiveness of PATADAY has not been established in pediatric patients &lt;18 years of age.<br />No overall difference in safety has been observed between pediatric and adult patients.</p><p><br /><strong>&bull; Geriatric population</strong><br />No overall differences in safety and effectiveness have been observed between elderly and other adult patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For topical ocular use only. Not for injection or oral use.<br /><strong>Dosing Considerations</strong><br />No special dosage considerations are necessary for PATADAY.<br /><strong>Recommended Dose and Dosage Adjustment</strong><br />The recommended dose is one drop in each affected eye once a day.<br />No dosage adjustment is required in hepatic or renal impairment.<br /><strong>Missed Dose</strong><br />If a dose is missed, a single drop should be taken as soon as possible before reverting to regular routine. Do not use a double dose to make up for the one missed.<br /><strong>Contamination</strong><br />As with any eye drop, to prevent contamination of the dropper tip and solution, care should be taken not to touch the eyelids or surrounding areas with the dropper tip of the bottle. Keep bottle tightly closed when not in use.<br />Patients should be advised not to wear contact lenses if their eye(s) are red.<br />PATADAY should not be used to treat contact lens related irritation.<br /><strong>Pediatrics</strong><br />Pediatrics (&lt;18 years): Effectiveness in pediatric patients has not been established. No overall difference in safety has been observed between pediatric and adult patients.<br /><strong>Geriatrics</strong><br />No overall differences in safety and effectiveness have been observed between elderly and other adult patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Patients who are hypersensitive to this drug or to any ingredient in the formulation or component of the container. see 6.1 List of excipients section.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The preservative in PATADAY, benzalkonium chloride, may cause eye irritation and is known to discolour soft contact lenses. Contact with soft contact lenses should be avoided. Patients must be instructed to remove contact lenses prior to application of PATADAY, and wait at least 15 minutes before they insert their contact lenses.<br />If using other eye drops, patients should wait at least five minutes between putting in PATADAY and the other drops. Eye ointments should be applied last.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No clinical interaction studies have been conducted with PATADAY. In vitro studies have shown that olopatadine does not inhibit metabolic reactions which involve cytochrome P-450 isoenzymes 1A2, 2C8, 2C9, 2C19, 2D6, 2E1 and 3A4. Olopatadine is moderately bound to plasma proteins (approximately 55%). These results indicate that olopatadine is unlikely to result in interactions with other concomitantly administered medications. Due to the low systemic exposure following topical ocular dosing, it is unlikely that PATADAY would interfere with immediate hypersensitivity skin testing.<br />Interactions with other drugs, food, herbal products or laboratory tests have not been established.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>&bull; Fertility</strong><br />Studies have not been performed to evaluate the effect of topical ocular administration of olopatadine on human fertility.<br /><strong>&bull; Pregnant Women</strong><br />There are no adequate and well controlled studies in pregnant women. Studies in animals with olopatadine have shown reproductive toxicity following systemic administration considered sufficiently in excess of the maximum human exposure. Olopatadine was found not to be teratogenic in rats and rabbits at oral doses &gt;90,000 and &gt;60,000 times the maximum recommended ocular human use level, respectively. Because animal studies are not always predictive of human responses, PATADAY should be used in pregnant women only if the potential benefit to the mother justifies the potential risk to the embryo or fetus.<br /><strong>&bull; Breast-feeding</strong><br />Olopatadine has been identified in the milk of nursing rats following oral administration. It is not known whether topical ocular administration could result in sufficient systemic absorption to produce detectable quantities in human breast milk. Nevertheless, caution should be exercised<br />when PATADAY is administered to a nursing mother.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Olopatadine is a non-sedating anti-histamine. Temporary blurred vision or other visual disturbances, after the use of PATADAY, may affect the ability to drive or use machines. If blurred vision occurs after instillation, patients must wait until vision clears before driving or using machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>&bull; Adverse Reaction Overview</strong><br />In clinical trials involving 1137 patients dosed with long-term ophthalmic topical therapy, PATADAY was administered once-daily for 4 to 12 weeks. The most frequently reported treatment-related undesirable effects were headache (0.8%), eye irritation (0.5%), dry eye (0.4%), and eyelid margin crusting (0.4%). No serious adverse drug reactions related to PATADAY were reported in the clinical trials.<br /><strong>&bull; Clinical Trial Adverse Reactions</strong><br />Clinical trials are conducted under very specific conditions. The adverse reaction rates observed in the clinical trials; therefore, may not reflect the rates observed in practice and should not be compared to the rates in the clinical trials of another drug. Adverse reaction information from clinical trials may be useful in identifying and approximating rates of adverse drug reactions in real-world use.<br />No treatment-related adverse drug reactions occurred at an incidence &ge; 1%.<br /><strong>&bull; Less Common Clinical Trial Adverse Reactions</strong><br />The most frequently reported adverse drug reactions (&gt;0.1%) are presented below.<br /><strong>Treatment-Related Adverse Drug Reactions &gt;0.1% &ndash; Long-Term Exposure</strong><br />Eye disorders: eye irritation, dry eye, eyelid margin crusting, and eye pruritus.<br />Gastrointestinal disorders: dry mouth.<br />Nervous system disorders: headache, dysgeusia.<br />Additional treatment-related adverse drug reactions that occurred at an incidence of 0.1% included the following:<br /><strong>Eye disorders:</strong> asthenopia, eye swelling, eyelid disorder, eyelids pruritus, ocular hyperaemia, and vision blurred.<br /><strong>Investigations:</strong> heart rate increased.<br /><strong>Respiratory, Thoracic, and Mediastinal disorders: </strong>nasal dryness<br /><strong>&bull; Post-Market Adverse Reactions</strong><br />Approximately 5.4 million units of PATADAY have been sold worldwide. The reporting rate of all reaction terms reported between 22 December 2004 and 31 August 2009 was 0.005%, and no single reaction term occurred with a reporting rate greater than 0.0007%. No post-market reports of serious adverse reactions have been received to date. The most frequent events reported being eye irritation, ocular hyperaemia, eye pain and vision blurred. There were no new major findings bearing on the established overall safety profile of PATADAY. Other events include dizziness, eye discharge, punctate keratitis, keratitis, erythema of eyelid, dermatitis contact, fatigue, hypersensitivity, ocular discomfort, lacrimation increased and nausea.<br /><strong>&bull; To report any side effect(s):<br />Saudi Arabia</strong><br />The National Pharmacovigilance Centre (NPC):<br />o SFDA call center: 19999<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: https://ade.sfda.gov.sa<br />Patient Safety Department Novartis Consulting AG - Saudi Arabia:<br />o Toll Free Number: 8001240078<br />o Phone: +966112658100<br />o Fax: +966112658107<br />o Email: adverse.events@novartis.com<br />&bull; Other GCC States:<br />- Please contact the relevant competent authority.<br /><strong>To report any complaint(s) :</strong> complaints.ksa@novartis.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No data are available in humans regarding overdose by accidental or deliberate ingestion of PATADAY. No reports of overdose were received during the clinical studies of PATADAY.<br />If a topical overdose of PATADAY occurs, the eye(s) may be flushed with tap water.<br /><strong>For management of suspected drug overdose, consult your regional poison control centre.</strong></p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>&bull; Mechanism of Action</strong><br />Olopatadine, a structural analog of doxepin, is a non-steroidal, non-sedating, topically effective anti-allergic molecule that exerts its effects through multiple distinct mechanisms of action. Olopatadine is a mast cell stabilizer and a potent, selective histamine H1 antagonist that inhibits the in vivo type 1 immediate hypersensitivity reaction. In vitro studies have demonstrated the ability of olopatadine to stabilize rodent basophils and human conjunctival mast cells and inhibit immunologically-stimulated release of histamine. In addition, Olopatadine inhibits the release of mast cell inflammatory mediators [i.e., histamine, tryptase, prostaglandin D2 and TNF&alpha;] as demonstrated in in vitro studies and confirmed in patients. Olopatadine is a selective histamine H1 receptor antagonist in vitro and in vivo as demonstrated by its ability to inhibit histamine binding and histamine-stimulated vascular permeability in the conjunctiva following topical ocular administration. Olopatadine is also an inhibitor of pro-inflammatory cytokine secretion from human conjunctival epithelial cells. Decreased chemotaxis and inhibition of eosinophil activation has also been reported. Olopatadine is devoid of effects on alpha-adrenergic, dopamine, muscarinic type 1 and 2, and serotonin receptors.<br /><strong>Effects on cardiac repolarization (QTc):</strong><br />Olopatadine had no observed effect on heart rate, cardiac conduction (PR and QRS interval duration), cardiac repolarization (QT duration) or wave form morphology relative to placebo in 2 double-masked, placebo controlled, 2-way crossover studies of 102 subjects given 5-mg oral doses of olopatadine every 12 hours for 2.5 days and 32 subjects given 20-mg oral doses twice-<br />daily for 13.5 days. No clinically relevant or statistically significant changes in mean QTcF (determined to be the most appropriate heart correction formula for both study populations) at steady-state from baseline were observed in either study. A categorical analysis of QTc (&lt; 30 ms, 30 ms-60 ms, or &gt; 60 ms) showed no statistically significant differences between olopatadine and placebo in both studies. An analysis of the maximal change from baseline in QTcF showed the difference was higher for placebo than for olopatadine. In addition, no evidence of QT interval prolongation was observed, relative to placebo, in 429 perennial allergic rhinitis patients given olopatadine hydrochloride nasal spray, 665 micrograms twice daily for up to 1 year.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Systemic bioavailability data upon topical ocular administration of PATADAY are not available.<br />Absorption:<br />Following topical ocular administration in man, olopatadine was shown to have low systemic exposure. Two studies in healthy volunteers (totalling 24 subjects) dosed bilaterally with Olopatadine 0.15% ophthalmic solution once every 12 hours for 2 weeks demonstrated plasma concentrations to be generally below the quantitation limit of the assay (&lt;0.5 ng/mL). Samples in which olopatadine was quantifiable were typically found within 2 hours of dosing and ranged from 0.5 to 1.3 ng/mL. These plasma concentrations were greater than 300 fold below those observed with a well-tolerated 20 mg oral multiple-dose regimen. In oral studies, olopatadine was found to be well absorbed.<br />In multiple oral dose studies, olopatadine plasma concentrations were shown to increase in proportion to the dose increment.<br /><strong>Metabolism:</strong><br />Approximately 60-70% of the oral dose was recovered in the urine as parent drug. Peak plasma concentrations of the active metabolite, N-desmethyl olopatadine and inactive N-oxide metabolite were low, less than 1% and 3% of parent, respectively. Two metabolites, the mono-desmethyl and the N-oxide, were detected at low concentrations in the urine.<br /><strong>Elimination:&nbsp;</strong>The elimination half-life in plasma was 7-14 hours, and elimination was predominantly through renal excretion.<br /><strong>Special Populations and Conditions</strong><br /><strong>&bull; Pediatrics </strong>- Effectiveness in paediatric patients has not been established. No overall difference in safety has been observed between paediatric and adult patients.<br /><strong>&bull; Geriatrics</strong> - No overall differences in safety and effectiveness have been observed between elderly and other adult patients.<br /><strong>&bull; Sex</strong> - In multiple oral dose studies, plasma concentrations of olopatadine are higher in female subjects, however, the differences are small and not clinically meaningful.<br /><strong>&bull; Ethnic Origin</strong> - No specific pharmacokinetic study examining the effect of race has been conducted.<br /><strong>&bull; Hepatic Insufficiency</strong> - No specific pharmacokinetic study examining the effect of hepatic impairment was conducted. Since metabolism of olopatadine is a minor route of elimination, no adjustment of the dosing regimen of PATADAY is warranted in patients with hepatic impairment<br /><strong>&bull; Renal Insufficiency </strong>- The mean plasma Cmax values for olopatadine following single intranasal doses of olopatadine hydrochloride nasal spray 0.6% (665 &mu;g/spray) were not markedly different between healthy subjects (18.1 ng/mL) and patients with mild, moderate and severe renal impairment (range 15.5 to 21.6 ng/mL). Plasma AUC was 2.5-fold higher in patients with severe impairment (creatinine clearance &lt;30 mL/min/1.73m2). Predicted peak steady-state plasma concentrations of olopatadine in patients with renal impairment following administration of olopatadine hydrochloride ophthalmic solution, 0.1% are at least 10-fold lower than those observed following administration of olopatadine nasal spray 0.6%, and approximately 300-fold lower than those observed following the safe and well-tolerated administration of 20 mg oral doses for 13.5 days. These findings indicate that no adjustment of the dosing regimen of PATADAY is warranted in patients with renal impairment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Olopatadine administered orally was not carcinogenic in mice and rats in doses up to 500 mg/kg/day and 200 mg/kg/day, respectively. Based on a 40 &mu;L drop size and a 50 kg person, these doses were approximately 150,000 and 50,000 times higher than the maximum recommended ocular human dose (MROHD) based on body weight comparison. No mutagenic potential was observed when olopatadine was tested in an in vitro bacterial reverse mutation (Ames) test, an in vitro mammalian chromosome aberration assay or an in vivo mouse micronucleus test. Olopatadine administered to male and female rats at oral doses of approximately 100,000 times MROHD level resulted in a slight decrease in the fertility index and reduced implantation rate; no effects on reproductive function were observed at doses of approximately 15,000(based on mg/kg) times the MROHD level.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Benzalkonium chloride (preservative)<br />Disodium phosphate<br />Edetate disodium<br />Hydrochloric acid and/or<br />Sodium hydroxide (to adjust pH)<br />Povidone<br />Purified water<br />Sodium chloride.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 Months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.<br />Discard the container at the end of treatment or 4 weeks after first opening whichever comes first. Keep out of the reach and sight of children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>PATADAY&reg; (olopatadine hydrochloride ophthalmic solution) 0.2% is supplied in a plastic<br />2.5 mL fill in 4 mL bottle</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The Marketing Authorization Holder for this Product is Novartis Pharma AG.
www.Novartis.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                This leaflet was prepared by Novartis Pharmaceuticals Canada Inc. on June 23,2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>